CureVac N.V. Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$572.38 | $591.94 | 8.32% | 1 | $218.49B |
| DHR | Danaher | Outperform |
10
|
$248.38 | $260.33 | 9.68% | 4 | $183.97B |
| PFE | Pfizer | Outperform |
2
|
$27.81 | $32.87 | 9.67% | 6 | $157.48B |
| SAN | Sanofi | Outperform |
16
|
91.30€ | 102.80€ | 19.39% | 9 | 114.00€B |
| GSK | GSK | Outperform |
12
|
£17.34 | £17.30 | 12.46% | 12 | £70.69B |
| MRNA | Moderna | Outperform |
16
|
$125.00 | $135.42 | 1.12% | 1 | $47.90B |
| BNTX | BioNTech | Outperform |
12
|
$92.72 | $123.75 | 8.58% | 3 | $22.34B |
| 1548 | Genscript Biotech | Buy |
5
|
HK$12.00 | HK$3.96 | -68.00% | 0 | HK$24.72B |
| TWST | Twist Bioscience | Outperform |
4
|
$41.21 | $34.00 | 6.77% | 2 | $2.40B |